Status:
COMPLETED
A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea
Lead Sponsor:
Dow Pharmaceutical Sciences
Conditions:
Rosacea
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.
Eligibility Criteria
Inclusion
- Presence of facial rosacea
- Presence of inflammatory lesions
Exclusion
- Dermatological conditions of the face that could interfere with clinical evaluations
- Known history of photosensitivity disorders (such as lupus erythematosus or polymorphous light eruption)
- Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00667173
Start Date
November 1 2007
End Date
July 1 2008
Last Update
February 20 2012
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Affiliated Research Center, Inc.
Huntsville, Alabama, United States, 35801
2
Therapeutics Clinical Research
San Diego, California, United States, 92123
3
Solano Clinical Research
Vallejo, California, United States, 94589
4
Cherry Creek Dermatology Research Inc.
Denver, Colorado, United States, 80246